Chelsea S Kidwell Selected Research

Chelsea S Kidwell Research Topics

Disease

36	Stroke (Strokes) 10/2018 - 06/2003
29	Ischemic Stroke 01/2018 - 01/2002
8	Cerebral Hemorrhage 01/2019 - 01/2002
4	Hemorrhage 02/2017 - 09/2004
4	Infarction (Infarctions) 01/2013 - 01/2005
3	Hematoma 01/2018 - 06/2013
3	Ischemia 06/2009 - 01/2003
3	Brain Ischemia (Cerebral Ischemia) 01/2008 - 12/2004
2	Edema (Dropsy) 10/2018 - 01/2018
2	Arterial Occlusive Diseases (Arterial Occlusive Disease) 12/2013 - 12/2002
2	Disease Progression 08/2011 - 05/2009
2	Transient Ischemic Attack 06/2009 - 12/2004
2	Embolism (Embolus) 01/2005 - 12/2004
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2005 - 12/2004
1	Sleep Apnea Syndromes (Sleep Apnea) 01/2021
1	Hypertension (High Blood Pressure) 01/2019
1	Brain Injuries (Brain Injury) 01/2018
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 10/2015
1	Cerebral Small Vessel Diseases 03/2015
1	Hypotension (Low Blood Pressure) 10/2011
1	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 08/2011
1	Reperfusion Injury 03/2010
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 06/2009
1	Cerebral Infarction 01/2005
1	Proteinuria 09/2004
1	Carotid Stenosis (Carotid Artery Stenosis) 09/2004
1	Diabetes Mellitus 09/2004
1	Pathologic Constriction (Stenosis) 09/2004
1	Atrial Fibrillation 09/2004
1	Thrombosis (Thrombus) 11/2003

Drug/Important Bio-Agent (IBA)

6	Biomarkers (Surrogate Marker)IBA 01/2018 - 01/2008
5	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2017 - 06/2003
3	Apolipoproteins E (ApoE)IBA 01/2019 - 08/2011
2	CholesterolIBA 01/2021 - 01/2005
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017 - 01/2005
2	GadoliniumIBA 03/2010 - 01/2008
2	Pharmaceutical PreparationsIBA 08/2005 - 01/2003
2	Warfarin (Coumadin)FDA LinkGeneric 01/2005 - 09/2004
2	Indicators and Reagents (Reagents)IBA 01/2005 - 11/2003
2	Neuroprotective AgentsIBA 05/2004 - 01/2003
1	ApolipoproteinsIBA 01/2019
1	Biological ProductsIBA 01/2018
1	Antihypertensive Agents (Antihypertensives)IBA 02/2017
1	HDL CholesterolIBA 11/2016
1	CollagenIBA 03/2015
1	PlasminogenIBA 07/2014
1	Mitochondrial DNA (mtDNA)IBA 03/2013
1	danaparoid (Orgaran)FDA Link 01/2012
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 10/2011
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 10/2011
1	Hemoglobins (Hemoglobin)IBA 10/2011
1	Lipoproteins (Lipoprotein)IBA 10/2011
1	neurotensin mimic 1IBA 03/2010
1	Matrix Metalloproteinases (MMPs)IBA 03/2010
1	Retinaldehyde (Retinal)IBA 06/2009
1	MagnesiumIBA 05/2009
1	Glucose (Dextrose)FDA LinkGeneric 05/2009
1	Ion Channels (Ion Channel)IBA 11/2008
1	ChemokinesIBA 11/2008
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 11/2008
1	N-Methylaspartate (NMDA)IBA 11/2008
1	CytokinesIBA 11/2008
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2008
1	Simvastatin (Zocor)FDA LinkGeneric 01/2005
1	DiureticsIBA 09/2004
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 09/2004
1	AnticoagulantsIBA 09/2004
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 09/2004
1	Angiotensin Receptor AntagonistsIBA 09/2004
1	3-hydroxy-7-methylcholanoic acid (HMCA)IBA 11/2003

Therapy/Procedure

27	Therapeutics 01/2017 - 12/2002
7	Embolectomy 10/2018 - 12/2004
6	Thrombectomy 10/2015 - 05/2011
4	Contraindications 07/2014 - 01/2002
3	Thrombolytic Therapy 01/2014 - 01/2002
1	Endovascular Procedures 10/2015
1	Diet Therapy (Therapy, Diet) 10/2011
1	Treatment Delay 08/2011
1	Time-to-Treatment 10/2010
1	Anesthesia 06/2009
1	Operative Surgical Procedures 01/2005
1	Secondary Prevention 12/2004
1	Carotid Endarterectomy 09/2004
1	Catheters 11/2003